Cytosorbents Corp

CTSO Nasdaq SEC CIK 1175151
Follow Cytosorbents Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $9.6M +0.2% vs same quarter last year
Net income −$4.4M −326.9% vs same quarter last year
EPS, diluted −$0.07 −333.3% vs same quarter last year
Operating cash flow −$583K +61.4% vs same quarter last year
Revenue by quarter
$8.6M
$9.2M
$8.7M
$9.6M
$9.5M
$9.2M
$8.9M
$9.6M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40M$60MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$37.1M−$8.2M
FY24$35.6M−$20.7M
FY23$31.1M−$29.2M
FY22$34.7M−$32.8M
FY21$43.2M−$24.6M
FY20$41M−$7.8M
FY19$24.9M−$19.3M
FY18$22.5M−$17.2M
FY17$15.2M−$8.5M
FY16$9.5M−$11.8M
FY15$4.8M−$9.5M
FY14$4.1M−$9.3M
FY13$2.4M−$4.7M
FY12$1.3M−$3.7M
FY11$36.1K−$5.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2571.5%−39.8%−22.1%
FY2469.9%−46.2%−58.2%
FY2370.6%−102.8%−94.1%
FY2259.8%−90.9%−94.6%
FY2174.4%−52.7%−56.9%
FY2073%−25.3%−19.1%
FY1970.5%−76%−77.2%
FY1866.7%−69.3%−76.5%
FY1763.6%−65%−55.8%
FY1658.5%−120.6%−123.5%
FY1553.8%−194.2%−197.8%
FY1448.2%−167.2%−226.1%
FY1321.1%−194.5%−193.1%
FY1276.2%−259.9%−272.8%
FY1167.4%−12297.7%−15193.9%
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$12.5M
FY24−$14.7M
FY23−$22.2M
FY22−$34.3M
FY21−$17.6M
FY20−$6.3M
FY19−$17.5M
FY18−$11.5M
FY17−$7.5M
FY16−$6.9M
FY15−$9.5M
FY14−$6.8M
FY13−$3.5M
FY12−$3.6M
FY11−$3.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Cytosorbents
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCytosorbentsHealthcare median
FY25−22.1%−30.6%
FY24−58.2%−47%
FY23−94.1%−58%
FY22−94.6%−80.4%
FY21−56.9%−71.8%
FY20−19.1%−62.2%
FY19−77.2%−46.2%
FY18−76.5%−49.6%
FY17−55.8%−45.9%
FY16−123.5%−36%
FY15−197.8%−37.8%
FY14−226.1%−35.5%
FY13−193.1%−37.1%
FY12−272.8%−29.1%
FY11−15193.9%−27.9%